T 2136/21 of 02.05.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T213621.20220502
- Date of decision
- 2 May 2022
- Case number
- T 2136/21
- Online on
- 10 May 2022
- Petition for review of
- -
- Application number
- 15733370.9
- IPC class
- C07K 14/135A61K 39/235
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Immunogenic combinations
- Applicant name
- GlaxoSmithKline Biologicals S.A.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 99(2)European Patent Convention R 101(1)European Patent Convention R 126(2)
- Keywords
- Admissibility of appeal - missing statement of grounds
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is rejected as inadmissible.